Skip to content

Drug interactions

Nadolol + Tucatinib

Severity: Moderate

Nadolol and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits P-glycoprotein, and nadolol is a substrate of this transporter, so its exposure may increase. This may lead to enhanced beta-blockade such as bradycardia or hypotension.

What this interaction means in plain words

Nadolol and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nadolol belongs to Cardiovascular; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibition of intestinal P-glycoprotein efflux increases nadolol absorption and exposure.

What to do

Monitor heart rate and blood pressure when starting tucatinib, and reduce the nadolol dose if bradycardia or hypotension develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nadolol and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nadolol with Tucatinib?

MediHelp rates the interaction as moderate. Nadolol and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits P-glycoprotein, and nadolol is a substrate of this transporter, so its exposure may increase. This may lead to enhanced beta-blockade such as bradycardia or hypotension.

How serious is the interaction between Nadolol and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and blood pressure when starting tucatinib, and reduce the nadolol dose if bradycardia or hypotension develops.

What other medicines interact with Nadolol?

MediHelp also lists interactions of Nadolol with, for example, Acebutolol, Adrenaline-articaine, Albuterol. The full list is on the Nadolol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in